These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 29548660)

  • 1. Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis.
    Sakata S; Matsuoka Y; Kawahara K; Kakiuchi Y; Takaki A; Hirosue A; Yoshida R; Saeki S; Fujii K; Nakayama H
    Respir Investig; 2018 Mar; 56(2):195-198. PubMed ID: 29548660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer.
    Kato T; Masuda N; Nakanishi Y; Takahashi M; Hida T; Sakai H; Atagi S; Fujita S; Tanaka H; Takeda K; Satouchi M; Namba Y; Tamura T
    Lung Cancer; 2017 Feb; 104():111-118. PubMed ID: 28212992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
    Stefani A; Natali P; Casali C; Morandi U
    Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Talc-induced interstitial pneumonitis with respiratory failure.
    Griffo S; Musumeci A; De Luca G; Saccenti A; Grande LM; Stassano P
    Anaesth Intensive Care; 2009 Jan; 37(1):127-9. PubMed ID: 19157360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Talc pleurodesis in pleuropulmonary diseases treatment.
    Ramić N; Krdžalić G; Mušanović N; Konjić F; Umihanić S; Ramić S; Mustedanagić-Mujanović J; Ljuca F; Zerem E
    Med Glas (Zenica); 2014 Aug; 11(2):264-9. PubMed ID: 25082238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Talc pleurodesis in recurrent malignant pleural effusion--a prospective follow-up study].
    Walter M; Türler A; Schmitz-Rixen T
    Zentralbl Chir; 1996; 121(3):216-22. PubMed ID: 8867348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A propensity score-matched comparison of the efficacies of OK-432 and talc slurry for pleurodesis for malignant pleural effusion induced by lung adenocarcinoma.
    Nohara K; Takada K; Kojima E; Ninomiya K; Miyamatsu S; Shimizu T; Sakurai T; Mizuno T; Yamashita Y
    Respir Investig; 2016 Sep; 54(5):341-6. PubMed ID: 27566382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis?
    Terra RM; Junqueira JJM; Teixeira LR; Vargas FS; Pêgo-Fernandes PM; Jatene FB
    Chest; 2009 Aug; 136(2):361-368. PubMed ID: 19349389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].
    Zhang W; Wang GF; Zhang H; Mu XD; Jin Z
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):600-2. PubMed ID: 19088831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial.
    Goodman A; Davies CW
    Lung Cancer; 2006 Oct; 54(1):51-5. PubMed ID: 16920219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of malignant pleural effusion by pleurodesis with talc].
    Filippetti M; Crucitti G; Vanni B; Della Giulia M; Foggi P; Del Monte G
    Chir Ital; 2000; 52(5):541-7. PubMed ID: 11190547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management.
    Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L
    BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Talc slurry pleurodesis via chest tube in department of pulmonology--a 24-case study.
    Gawron G; Gabryś J; Barczyk A
    Pneumonol Alergol Pol; 2013; 81(5):439-47. PubMed ID: 23996883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathway.
    Ahmed L; Ip H; Rao D; Patel N; Noorzad F
    Chest; 2014 Dec; 146(6):e190-e194. PubMed ID: 25451360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results.
    Basso SM; Mazza F; Marzano B; Santeufemia DA; Chiara GB; Lumachi F
    Anticancer Res; 2012 Nov; 32(11):5131-4. PubMed ID: 23155293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review.
    Tan C; Sedrakyan A; Browne J; Swift S; Treasure T
    Eur J Cardiothorac Surg; 2006 May; 29(5):829-38. PubMed ID: 16626967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of recurrent malignant pleural effusion with chemical pleurodesis.
    Kilic D; Akay H; Kavukçu S; Kutlay H; Cangir AK; Enön S; Kadilar C
    Surg Today; 2005; 35(8):634-8. PubMed ID: 16034542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
    Kolschmann S; Ballin A; Gillissen A
    Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
    Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
    J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleurodesis in recurrent pleural effusions: a randomized comparison of a classical and a currently popular drug.
    Ukale V; Agrenius V; Hillerdal G; Mohlkert D; Widström O
    Lung Cancer; 2004 Mar; 43(3):323-8. PubMed ID: 15165091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.